Published in Blood on August 01, 1990
Deferasirox pharmacokinetics in patients with adequate versus inadequate response. Blood (2009) 1.04
QTc Interval and QT Dispersion in Patients with Thalassemia Major: Electrocardiographic (EKG) and Echocardiographic Evaluation. Clin Med Insights Cardiol (2010) 0.92
The thalassemias and health care in Canada: a place for genetics in medicine. CMAJ (1991) 0.85
Atrial Fibrillation and Beta Thalassemia Major: The Predictive Role of the 12-lead Electrocardiogram Analysis. Indian Pacing Electrophysiol J (2014) 0.84
Rod and rod mediated function in patients with beta-thalassemia major. Doc Ophthalmol (2000) 0.82
Beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects. Mediterr J Hematol Infect Dis (2013) 0.80
The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients. J Interv Card Electrophysiol (2016) 0.78
Thyroid function status and echocardiographic abnormalities in patients with Beta thalassemia major in bahrain. Clin Med Insights Cardiol (2013) 0.78
Congenital sideroblastic anaemia in two girls. J Clin Pathol (1991) 0.78
The pro-BNP Serum Level and Echocardiographic Tissue Doppler Abnormalities in Patients with Beta Thalassemia Major. Clin Med Insights Cardiol (2010) 0.77
Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: a systematic review. BMC Blood Disord (2002) 0.77
Evaluating the Correlation between Serum NT-proBNP Level and Diastolic Dysfunction Severity in Beta-Thalassemia Major Patients. J Tehran Heart Cent (2016) 0.77
Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives. J Blood Med (2016) 0.76
Desferrioxamine provocative test: methodology for estimating iron and total iron binding capacity. Blood (1990) 0.75
Treatment of Cooley's anemia: deferoxamine provocation test. Blood (1990) 0.75
Positive and negative elements regulate human interleukin 3 expression. Proc Natl Acad Sci U S A (1990) 7.44
Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med (1968) 6.91
Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med (1994) 5.32
Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature (1984) 5.10
Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. N Engl J Med (1978) 4.34
Leukocyte oxidase: defective activity in chronic granulomatous disease. Science (1967) 4.25
Globin chain synthesis in the alpha thalassemia syndromes. J Clin Invest (1969) 2.46
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest (1984) 2.43
The molecular basis of alpha-thalassemias: frequent occurrence of dysfunctional alpha loci among non-Asians with Hb H disease. Cell (1979) 2.41
Disorders of phagocytic cell function. Prog Hematol (1971) 2.37
Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature (1986) 2.36
Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro. J Exp Med (1978) 2.33
Continuous subcutaenous administration of deferoxamine in patients with iron overload. N Engl J Med (1977) 2.31
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines. Blood (1989) 2.13
Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. J Clin Invest (1969) 2.11
Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med (1967) 2.06
Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J Clin Invest (1970) 2.04
Thalassemia: the consequences of unbalanced hemoglobin synthesis. Am J Med (1966) 2.03
Opportunities for medical research in the 21st century. JAMA (2001) 2.01
Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia. Proc Natl Acad Sci U S A (1979) 1.94
Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin. Science (1985) 1.86
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
Antenatal diagnosis of haematological disorders--'1978'. Clin Haematol (1978) 1.78
Oxidant injury of caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection. J Clin Invest (1971) 1.72
Prenatal diagnosis of hemoglobinopathies. A review of 15 cases. N Engl J Med (1976) 1.69
Antenatal diagnosis of thalassaemia major. Br Med J (1978) 1.64
Mild thalassemia: the result of interactions of alpha and beta thalassemia genes. J Clin Invest (1970) 1.59
Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med (1984) 1.54
Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate. Exp Hematol (1992) 1.50
Stages in the incorporation of fatty acids into red blood cells. J Clin Invest (1968) 1.49
Diamond-Blackfan anemia. Natural history and sequelae of treatment. Medicine (Baltimore) (1996) 1.46
Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood (1975) 1.46
A revived opportunity for fetal research. Nature (1993) 1.40
Reassessment of the use of desferrioxamine B in iron overload. N Engl J Med (1976) 1.40
An orally active iron chelator. N Engl J Med (1995) 1.40
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res (1983) 1.39
Congenital hemolytic anemia with high-sodium, low-potassium red cells. Studies of three generations of a family with a new variant. N Engl J Med (1969) 1.37
Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity. J Clin Invest (1985) 1.36
Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. Blood (1974) 1.36
Congenital hemolytic anemia with high sodium, low potassium red cells. I. Studies of membrane permeability. N Engl J Med (1968) 1.36
Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med (1978) 1.35
Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cells. Blood (1978) 1.34
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest (1987) 1.33
Erythroid precursors in congenital hypoplastic (Diamond-Blackfan) anemia. J Clin Invest (1978) 1.33
Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med (1985) 1.30
Fetal erythropoiesis following bone marrow transplantation. Blood (1976) 1.26
Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science (1988) 1.26
Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc (1972) 1.25
Equal synthesis of - and -globin chains in erythroid precursors in heterozygous -thalassemia. J Clin Invest (1972) 1.25
THE TURNOVER OF HEMOGLOBINS A, F, AND A(2) IN THE PERIPHERAL BLOOD OF THREE PATIENTS WITH THALASSEMIA. J Clin Invest (1963) 1.20
The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood (1997) 1.18
Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia. N Engl J Med (1987) 1.17
Beta thalassemia and translation of globin messenger RNA. Proc Natl Acad Sci U S A (1971) 1.16
Gamma-beta thalassemia: a cause of hemolytic disease of the newborn. N Engl J Med (1972) 1.16
Transfusion management of sickle cell disease. Blood (1993) 1.14
Congenital hemolytic anemia associated with dehydrated erythrocytes and increased potassium loss. N Engl J Med (1974) 1.13
Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease. Blood (2001) 1.12
New approaches to the transfusion management of thalassemia. Blood (1980) 1.12
Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Lancet (1982) 1.10
Influence of hemoglobin precipitation on erythrocyte metabolism in alpha and beta thalassemia. J Clin Invest (1969) 1.09
Sodium and potassium concentration and transmembrane fluxes in leukocytes. Blood (1974) 1.08
Acquired aplastic anemias: pathophysiology and treatment. Adv Intern Med (1982) 1.07
Endogenous production of carbon monoxide in normal and erythroblastotic newborn infants. J Clin Invest (1971) 1.07
Hemoglobin synthesis in human BFU-E and CFU-E-derived erythroid colonies. Blood (1979) 1.06
Detection of the sickle gene in the human fetus. Potential for intrauterine diagnosis of sickle-cell anemia. N Engl J Med (1972) 1.06
Heterogeneity of DNA deletion in gamma delta beta-thalassemia. J Clin Invest (1981) 1.04
Influence of erythrocyte membrane adenosine triphosphatase on the metabolism of hemolysates. J Lab Clin Med (1970) 1.03
Energy metabolism in human erythrocytes. I. Effects of sodium fluoride. J Clin Invest (1971) 1.03
Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man. J Clin Invest (1983) 1.02
Thalassemia. N Engl J Med (1972) 1.02
Mature bone marrow erythroid burst-forming units do not require T cells for induction of erythropoietin-dependent differentiation. J Exp Med (1980) 1.02
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. Blood (1985) 1.00
Editorial: NBT reduction by human phagocytes. N Engl J Med (1974) 1.00
Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation. J Clin Invest (1973) 1.00
Beta-thalassemia due to two novel nucleotide substitutions in consensus acceptor splice sequences of the beta-globin gene. Blood (1989) 1.00
Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin. J Clin Invest (1986) 1.00
Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease. Circulation (1970) 1.00
Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3. J Clin Invest (1987) 0.99
Energy metabolism in human erythrocytes: the role of phosphoglycerate kinase in cation transport. Blood (1975) 0.99
Relation of beta to gamma synthesis during the first trimester: an approach to prenatal diagnosis of thalassemia. Pediatr Res (1974) 0.98
Energy metabolism in human erythrocytes. II. Effects of glucose depletion. J Clin Invest (1972) 0.98
Expression of the beta-thalassemia gene in the first trimester fetus. Proc Natl Acad Sci U S A (1975) 0.97
Energy reserve and cation composition of irreversibly sickled cells in vivo. Br J Haematol (1978) 0.97
Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Cancer Res (1983) 0.96
Concentration of fetal red blood cells from a mixture of maternal and fetal blood by anti-i serum--an aid to prenatal diagnosis of hemoglobinopathies. Blood (1974) 0.96
Analysis of hemoglobin F production in Saudi Arabian families with sickle cell anemia. Blood (1987) 0.95
Combinations of recombinant colony-stimulating factors are required for optimal hematopoietic differentiation in serum-deprived culture. Blood (1989) 0.95
Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood (1985) 0.94
Differential binding of erythroid and myeloid progenitors to fibroblasts and fibronectin. Blood (1987) 0.94
Reticulocyte survival in sickle cell anemia: effect of cyanate. Blood (1972) 0.94
Unbalanced globin chain synthesis in alpha-thalassemia heterozygotes. Ann N Y Acad Sci (1969) 0.94
The mortality of acquired aplastic anemia in children. Blood (1972) 0.94
A functional isoform of the human granulocyte/macrophage colony-stimulating factor receptor has an unusual cytoplasmic domain. Proc Natl Acad Sci U S A (1991) 0.94
The erythrocythaemic effects of androgen. Br J Haematol (1968) 0.93
Incorporation of phosphatide precursors from serum into erythrocytes. Biochim Biophys Acta (1970) 0.93
Control of the simian fetal hemoglobin switch at the progenitor cell level. J Clin Invest (1981) 0.93
Synthesis of hemoglobin F in adult simian erythroid progenitor-derived colonies. J Clin Invest (1982) 0.93